Herceptin is usually administered intravenously, often in combination with other chemotherapy drugs. The treatment regimen can vary depending on whether it is being used for early-stage or metastatic cancer. Typically, it is given every three weeks for a total of one year in early-stage breast cancer, though the schedule may differ for metastatic cases.
